[1] |
Gedi Zhang, Gengxin Liu, Ziyou Yan.
Therapeutic efficacy evaluation and mechanism of action based on meta-analysis and network pharmacology of Li Chong Decoction (Bolus) for cancer treatment
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 720-735.
|
[2] |
Kexin Wang, Shengnan Tian, Jia Wang, Jin Jin, Tingting Wang, Licang Zhang, Huanlong Liu.
Investigation and research on medication risk of Shijiazhuang urban residents based on KAP Theory
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 755-763.
|
[3] |
Chunyan Xie, Feng Yue, Haoquan Yu, Canzhong Huang, Shaoqun Zeng.
Evaluation of the stability of droplets in emulsion using multisample analytical centrifugation
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 574-586.
|
[4] |
Jinghua Su, Chao Zhang, Lei Sun, Shuangcheng Ma, Yiwen Xing.
Establishment of a variety identification system for Fritillaria Thunbergii Bulbus and Fritillaria Cirrhosae Bulbus based on nucleosides and nucleobases with multivariate analysis and pattern recognition
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(5): 406-416.
|
[5] |
Ciyan Peng, Jing Chen, Sini Li, Jianhe Li, Liubao Peng.
Evidence-based pharmacoeconomic evaluation of palbociclib in combination with letrozole versus docetaxel in combination with epirubicin in the first-line treatment of advanced breast cancer with epirubicin
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 214-222.
|
[6] |
Jia Ge, Longfei Chen, Xiaoyan Nie, Jing Chen.
Analysis of patent development status of lipid nanoparticle delivery system for mRNA vaccines
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 112-121.
|
[7] |
Yizheng Sun, Ying Qu, Xiaoyan Liu, Wei Xu, Youbo Zhang.
Comparative study on ginsenosides of ginsengs from different regions
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(12): 961-970.
|
[8] |
Yajing Li, Yawen Bai, Yu Du, Changhong Yan, Chunjie Ma, Lining Sun, Fengyue Bu, Haoyang Yan.
Yu Ping Feng Powder for chronic glomerulonephritis treatment: A meta-analysis and network pharmacology study
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(12): 1006-1026.
|
[9] |
Xinyu Chang, Lijuan Han, Yang Liu, Zheng Fan, Jiankun Wu.
Analysis of adverse drug reactions caused by carbapenems and review of related literature
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(10): 835-841.
|
[10] |
Limei Su, Xiyue Mao, Limei Yang.
Efficacy and safety of venous thromboembolism prevention in lung cancer: a meta-analysis of randomized controlled studies
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(10): 852-860.
|
[11] |
Ye Yuan, Bo Yu, Zhenzhen Yang, Weichong Dong, Xiuling Yang.
Pharmacological monitoring and literature analysis of dagliflozin in patients with hypovolemia
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(9): 718-722.
|
[12] |
Min Li, Lulu Chang, Xiangfeng Yue, Shuzhang Du.
Efficacy and safety of ACEI plus tanshinone for acute exacerbation of pulmonary heart disease: a meta-analysis
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(11): 853-865.
|
[13] |
Yingguang Sun, Yuanyuan Yue, Jiemin Shao, Meng Gao, Yanru Deng, Yunjia Feng.
A comparison of the effects of Kangfuxin liquid and watermelon frost spray for recurrent aphthous stomatitis: A meta-analysis
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(10): 761-772.
|
[14] |
Weiwei Jiang, Haiyan Quan, Lu He, Xing Jiang.
The diagnostic and prognostic value of CCTs in human hepatocellular carcinoma: a study based on integrated bioinformatics
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(10): 782-797.
|
[15] |
Sibei Qin, Tong Jia, Yu Fu, Junlei Li, Xinyi Zhang, Chunsu Zhu, Guangkai Liang, Xiaoyan Nie, Luwen Shi, Yimin Cui.
Association between CYP3A4 gene polymorphisms and clopidogrel response in patients with cardio-cerebrovascular diseases: a systematic review and Meta-analysis
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(9): 762-772.
|